CN1355707A - 使用白细胞介素－11治疗出血性休克 - Google Patents

使用白细胞介素－11治疗出血性休克 Download PDF

Info

Publication number
CN1355707A
CN1355707A CN00808737A CN00808737A CN1355707A CN 1355707 A CN1355707 A CN 1355707A CN 00808737 A CN00808737 A CN 00808737A CN 00808737 A CN00808737 A CN 00808737A CN 1355707 A CN1355707 A CN 1355707A
Authority
CN
China
Prior art keywords
rhil
interleukin
hemorrhagic shock
animals
shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00808737A
Other languages
English (en)
Chinese (zh)
Inventor
马修·波雷克
小詹姆斯·C·凯思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of CN1355707A publication Critical patent/CN1355707A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN00808737A 1999-06-08 2000-06-08 使用白细胞介素－11治疗出血性休克 Pending CN1355707A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13805499P 1999-06-08 1999-06-08
US60/138,054 1999-06-08

Publications (1)

Publication Number Publication Date
CN1355707A true CN1355707A (zh) 2002-06-26

Family

ID=22480226

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00808737A Pending CN1355707A (zh) 1999-06-08 2000-06-08 使用白细胞介素－11治疗出血性休克

Country Status (9)

Country Link
EP (1) EP1185292B1 (enExample)
JP (1) JP2003501396A (enExample)
CN (1) CN1355707A (enExample)
AT (1) ATE294590T1 (enExample)
AU (1) AU5328800A (enExample)
CA (1) CA2376358A1 (enExample)
DE (1) DE60019921T2 (enExample)
MX (1) MXPA01012663A (enExample)
WO (1) WO2000074707A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11

Also Published As

Publication number Publication date
DE60019921T2 (de) 2006-02-16
JP2003501396A (ja) 2003-01-14
MXPA01012663A (es) 2004-10-14
EP1185292A2 (en) 2002-03-13
EP1185292B1 (en) 2005-05-04
DE60019921D1 (de) 2005-06-09
AU5328800A (en) 2000-12-28
WO2000074707A3 (en) 2001-04-19
CA2376358A1 (en) 2000-12-14
ATE294590T1 (de) 2005-05-15
WO2000074707A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
JP2752206B2 (ja) 顆粒球コロニー刺激因子を用いる粘膜炎の予防及び治療法
EP0428573B1 (en) Method and compositions for the treatment and prevention of septic shock
AU672606B2 (en) Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
JP3813440B2 (ja) コンセンサスインターフェロンを使用する多発性硬化症患者の治療方法
EP0585705A1 (en) Use of anti-TNF to treat bacterial meningitis
US5437863A (en) Method of enhancing the growth of gut epithelial cells by administration of a cytokine such as interleukin II
US20050176631A1 (en) Method for reducing morbidity and mortality in critically ill patients
US20100210510A1 (en) Oral lactoferrin in the treatment of sepsis
CN1097468C (zh) 含有粒细胞集落刺激因子和肿瘤坏死因子结合蛋白的产物
US5660826A (en) Therapeutic sepsis treatment using antagonists to PTHrP
JP2528114B2 (ja) 腫瘍壊死因子を含んで成る組成物
CN1355707A (zh) 使用白细胞介素－11治疗出血性休克
Sheppard et al. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor
CN1251043A (zh) 可从动物器官中提取的蛋白质在制备可用于治疗疾病的药物中的用途
US20090285775A1 (en) Treatment of wounds using il-17b
EP0262802A2 (en) Medicament for the treatment or improvement of rheumatoid arthritis or systemic lupus erythematosus
US6086868A (en) Method for treating or preventing ischemia-reperfusion injury
CA2669109A1 (en) Il-17b for use in wound healing
RU2190634C2 (ru) Полимерные матрицы и их применение в фармацевтических составах
HK1030157B (en) Use of consensus interferon and compositions comprising consensus interferon
WO1990001328A1 (en) Tnf and formulations thereof in the treatment or prophylaxis of hepatitis b
CN1501807A (zh) 蛋白质uk114或其片段在治疗和预防内毒素性休克中的用途
MXPA00001207A (en) Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon
HK1025908A (en) The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor
HK1009403B (en) Tnf receptor and steroid hormone dhea in a combined therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication